GleanMark

VONENTIAL Trademark

VONENTIAL is a USPTO trademark filed by Pfizer Inc.. Status: Pending.

Prosecution Summary

**Trademark Summary** The standard character mark **VONENTIAL** covers pharmaceutical preparations in International Class 005 for treating various diseases and disorders including autoimmune, cardiovascular, infectious, inflammatory, cancer, pain, obesity and diabetes, as well as anti-infectives, medicated dermatologicals, antifungals, smoking cessation preparations and vaccines; it also spans domestic classes 006, 018, 044, 046, 051 and 052. Owned by **Pfizer Inc.**, a Delaware corporation based in New York, the application is on an intent-to-use basis. It is currently **suspended**, with an office action suspending further action sent to the applicant on January 12, 2026. **Recent Activity** Filed on October 9, 2025, the application entered the office supplied data phase and receive

Trademark Facts

MarkVONENTIAL
Serial Number99434593
StatusPending
Filing Date2025-10-09
Mark TypeWord
Nice Classes005 (Pharmaceuticals)
OwnerPfizer Inc.
Attorney of RecordHeather A. McDonald
Prosecution Events7
Latest EventCNSL on 2026-01-12

Goods & Services

Class 005: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use

Related